Who are the key players in North America Peripheral Vascular Devices Market industry?

The key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company (BD), and Cook Medical. These companies offer a broad range of innovative devices, robust R&D capabilities, and extensive distribution networks, solidifying their leading positions within the competitive North American peripheral vascular devices market.

Which segment accounted for the largest North America Peripheral Vascular Devices Market share?

Angioplasty balloons accounted for the largest share in the North America Peripheral Vascular Devices Market. These devices are widely used for minimally invasive treatment of vascular blockages, favoring their adoption due to high procedural success rates and technological advancements in balloon design for improved patient outcomes.

What are the factors driving the North America Peripheral Vascular Devices Market?

Key drivers include the growing incidence of lifestyle-related vascular diseases and technological advancements. For example, Abbott Laboratories’ launch of new peripheral stent technologies has improved efficacy and safety profiles, thereby increasing adoption among healthcare providers and contributing significantly to market growth.

Which type accounted for the largest North America Peripheral Vascular Devices Market share?

Peripheral stents accounted for the largest share of the North America Peripheral Vascular Devices Market. Their widespread use in treating arterial blockages, coupled with continual product innovation and improved patient outcomes, have established peripheral stents as the dominant device type in this sector.

Home Healthcare

North America Peripheral Vascular Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Peripheral Vascular Devices Market
Brand: Bussiness Insights

North America Peripheral Vascular Devices Market: by Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Inferior Vena Cava Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices), Application (Peripheral Artery Disease, Venous Thromboembolism, Aneurysm, Chronic Venous Insufficiency, Other Applications), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors/Wholesalers, Hospital Pharmacies, Others), Technology (Conventional, Drug-eluting, Bioabsorbable, Cutting-edge, Laser-assisted, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20459

North America Peripheral Vascular Devices Market Outlook, 2025-2035

The North America Peripheral Vascular Devices Market is witnessing robust growth driven by increasing cases of peripheral artery disease (PAD), technological advancements, and the rising adoption of minimally invasive procedures. Major medical device manufacturers are focusing on innovative product offerings targeting enhanced patient outcomes, which is elevating market competitiveness and expanding the applications of vascular devices in clinical practice. A positive reimbursement environment and a strong regulatory framework further support market expansion. The region is expected to sustain its dominant position globally, with significant contributions from the U.S. and Canada. The market outlook through 2035 remains highly optimistic, underpinned by progressive healthcare infrastructure and strategic initiatives by leading players.

Latest Market Dynamics

Key Drivers

Growing prevalence of peripheral artery disease and associated lifestyle risk factors such as diabetes and obesity, with Boston Scientific expanding its product portfolio to address rising clinical needs.

Rapid technological advancements, especially development of drug-eluting and bioabsorbable stents, led by Abbott Laboratories introducing next-generation bioabsorbable stents in North America.

Increased focus on minimally invasive procedures; Medtronic has launched next-gen angioplasty balloons supporting faster recovery and reduced hospital stays.
Integration of digital health and remote monitoring technologies in vascular care, with Philips Healthcare rolling out advanced imaging and monitoring solutions for peripheral interventions.

Key Opportunities

Growing demand for advanced vascular devices in outpatient and ambulatory surgical centers, with Terumo Corporation strategically expanding its distribution network for same-day procedures.
Rising adoption of bioabsorbable and cutting-edge technologies providing patients with safer, longer-lasting outcomes, as demonstrated by Stryker Corporation’s investment in bioabsorbable device R&D.

Regulatory complexities and the lengthy approval process for innovative vascular devices, challenging the go-to-market timelines for companies like Endologix LLC.
High competition and price pressure from generics and local manufacturers, as experienced by Cook Medical in cost-sensitive segments.

Stringent reimbursement policies and reductions in procedure payments, impacting players like Cardinal Health and their hospital contracts.
Risks related to device recalls and post-market surveillance requirements, as seen in recent FDA safety advisories involving certain angioplasty balloons.

North America Peripheral Vascular Devices Market Share (%) By Type, 2025

The breakdown by type in the North America market highlights the dominance of angioplasty balloons, which are valued for their effectiveness and widespread use in minimally invasive vascular interventions. Angioplasty stents also contribute significantly owing to growing preference for long-term vessel patency solutions. Catheters are critical in the delivery and navigation of devices, ensuring procedural success. Technological improvements and a focus on optimizing patient outcomes continue to shape the product landscape, while the entry of innovative hemodynamic and plaque modification devices hints at the segment's dynamic evolution. The market reflects a balanced distribution, with leading companies continuously investing in state-of-the-art device platforms.

North America Peripheral Vascular Devices Market Share (%) By Application, 2025

Peripheral artery disease (PAD) is the leading application segment, reflecting the high disease burden and growing geriatric population across North America. Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, also represents a significant portion, underscoring the need for effective interventional therapies. The treatment of aneurysms and chronic venous insufficiency further propels market adoption as device options diversify. Enhanced awareness, progressive clinical guidelines, and the migration toward early diagnosis and intervention are cementing the relevance of these applications, sustaining robust market expansion in healthcare institutions.

North America Peripheral Vascular Devices Market Revenue (USD Million), 2020-2035

The North America peripheral vascular devices market has shown a consistent growth trend from 2020 and is projected to continue expanding through 2035. In 2025, the market is estimated to reach USD 7,200 million, with increasing procedural volumes and rapid adoption of advanced technologies across both public and private healthcare settings. This growth is fueled by aging demographics, higher disease incidence, and continuous investment in R&D by market leaders. The revenue trajectory signals both short-term acceleration from new device launches and long-term opportunities driven by preventive healthcare initiatives and value-based care models.

North America Peripheral Vascular Devices Market YOY Growth (%), 2020-2035

The year-on-year (YOY) growth for the North America peripheral vascular devices market hovers around 5-6% in the near term, reflecting both organic expansion and new product introductions. As competition intensifies and mature segments stabilize, the growth rate slightly moderates toward the end of the forecast period. Continuous clinical innovation and expanded indications for device use are expected to ensure steady growth, with peaks corresponding to breakthrough product launches and regulatory approvals.

North America Peripheral Vascular Devices Market Share (%) By Country, 2025

The U.S. dominates the North American market for peripheral vascular devices, capturing the majority share due to its advanced healthcare infrastructure, substantial investments in R&D, and high prevalence of cardiovascular diseases. Canada is the second largest, with a strong emphasis on early intervention programs, while Mexico is witnessing burgeoning opportunities driven by rising healthcare awareness and expanding medical facilities. Regional disparities in reimbursement and access contribute to variations in market penetration, but overall, North America remains a global center for vascular innovation.

North America Peripheral Vascular Devices Market Share (%) By Player, 2025

Medtronic continues to lead the North America peripheral vascular devices market, leveraging its extensive portfolio and clinical expertise. Boston Scientific and Abbott Laboratories also command significant shares, propelled by their innovation-led pipelines and strategic partnerships. The competitive landscape is marked by both multinational giants and agile regional players, driving continual improvements in technology and affordability. The top three players collectively constitute over half of the market, reflecting strong brand loyalty and clinical confidence in their products.

North America Peripheral Vascular Devices Market Share (%) By Buyer, 2025

Hospital pharmacies account for the largest share of peripheral vascular device procurement, given their central role in acute and elective procedures. Distributors/wholesalers and direct tenders also hold substantial market shares, facilitating broad access across diverse healthcare settings. The rise of retail and online sales channels is reshaping distribution, although regulatory oversight remains robust. The evolving landscape emphasizes the need for agile supply chains and responsive procurement strategies as healthcare models shift.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	7200
Regions	North America, US, Canada, Mexico
Segments	By Type, By Application, By Distribution Channel, By Technology, By Organization Size
Players	Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson and Company (BD), Terumo Corporation, Cook Medical, Cardinal Health, B. Braun Melsungen AG, Philips Healthcare, AngioDynamics, Merit Medical Systems, Stryker Corporation, Asahi Intecc Co., Ltd., Endologix LLC, Cardinal Health, Inc.

Key Recent Developments

June 2024: Medtronic receives FDA approval for its next-generation drug-eluting peripheral stent, expanding US market access.
July 2024: Boston Scientific launches the EkoSonic Endovascular System for treating pulmonary embolism, advancing minimally invasive solutions.
August 2024: Abbott Laboratories partners with major US health systems to pilot AI-driven vascular imaging technologies.
September 2024: Terumo Corporation announces expansion of its manufacturing facility in North America to meet rising demand.
October 2024: Phillips Healthcare introduces new integrated digital vascular navigation platform at a leading interventional conference.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates